论文部分内容阅读
美国食品药品管理局(FDA)近日公布了一项新的合作倡议,他们将与总部位于休斯敦的“纳米健康联盟(ANH)”及其8个成员机构共同努力,在新兴纳米技术领域内加快研发安全、有效的医药和个人护理产品。
The U.S. Food and Drug Administration (FDA) recently announced a new partnership that will work with the Houston-based ANH and its eight member agencies to address emerging nanotechnology issues Accelerate the development of safe and effective pharmaceutical and personal care products.